DailyStocks Stock Article Search

https://www.zacks.com/commentary/2212742/top-research-reports-for-microsoft-procter-gamble-astrazeneca?cid=CS-ZC-FT-research_daily-2212742 Jan 19, 2024 - Today's Research Daily features new research reports on 16 major stocks, including Microsoft Corporation (MSFT), The Procter & Gamble Company (PG) and AstraZeneca PLC (AZN). 0

https://www.zacks.com/stock/news/2213619/what-s-in-the-cards-for-lam-research-lrcx-in-q2-earnings?cid=CS-ZC-FT-analyst_blog|earnings_preview-2213619 Jan 22, 2024 - Lam Research's (LRCX) fiscal second-quarter 2024 results are expected to reflect strength in 3D DRAM and advanced packaging amid a slowdown in memory spending. 0

https://www.zacks.com/stock/news/2230884/lam-research-lrcx-is-considered-a-good-investment-by-brokers-is-that-true?cid=CS-ZC-FT-fundamental_analysis|average_broker_rating-2230884 Feb 23, 2024 - Based on the average brokerage recommendation (ABR), Lam Research (LRCX) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying? 0

https://www.zacks.com/commentary/2235274/top-research-reports-for-broadcom-totalenergies-lam-research?cid=CS-ZC-FT-research_daily-2235274 Mar 04, 2024 - Today's Research Daily features new research reports on 16 major stocks, including Broadcom Inc. (AVGO), TotalEnergies SE (TTE) and Lam Research Corp. (LRCX). 0

https://www.zacks.com/stock/news/2239200/wall-street-analysts-think-lam-research-lrcx-is-a-good-investment-is-it?cid=CS-ZC-FT-fundamental_analysis|average_broker_rating-2239200 Mar 12, 2024 - Based on the average brokerage recommendation (ABR), Lam Research (LRCX) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying? 0

https://www.zacks.com/stock/news/2241688/lam-research-lrcx-suffers-a-larger-drop-than-the-general-market-key-insights?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_6v1-2241688 Mar 15, 2024 - Lam Research (LRCX) closed at $910.09 in the latest trading session, marking a -1.68% move from the prior day. 0

https://www.zacks.com/stock/news/2251990/the-zacks-analyst-blog-highlights-nvidia-lam-research-applied-materials-micron-technology-and-acm-research?cid=CS-ZC-FT-press_releases-2251990 Apr 08, 2024 - NVIDIA, Lam Research, Applied Materials, Micron Technology and ACM Research are part of the Zacks top Analyst Blog. 0

https://www.zacks.com/stock/news/2255546/will-lam-research-lrcx-beat-estimates-again-in-its-next-earnings-report?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_7-2255546 Apr 15, 2024 - Lam Research (LRCX) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report. 0

https://www.zacks.com/stock/news/2256989/sap-set-to-report-q1-earnings-here-s-what-you-should-know?cid=CS-ZC-FT-analyst_blog|earnings_preview-2256989 Apr 17, 2024 - SAP's first-quarter performance is likely to have benefited from continued momentum in cloud business. However, prevailing global macroeconomic challenges may have acted as a dampener. 0

https://www.zacks.com/stock/news/2258678/lam-research-lrcx-upgraded-to-buy-what-does-it-mean-for-the-stock?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_12_zacks_rank_upgrade-2258678 Apr 19, 2024 - Lam Research (LRCX) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term. 0